$XAIR

Biotech gainers on Monday included Universe Pharmaceuticals (UPC), which reported six-month ended March 31, 2026 revenue of $9.03 million and net loss of $1.55 million, and shares rose about 99% to $6.48. Cumberland Pharma (CPIX) rose over 38% ahead of Q2 results after a $100 million branded portfolio sale. Autolus (AUTL) gained about 22% on preliminary Q2 Aucatzyl net product revenue of about $45 million. Other movers included Pulmonx (LUNG), SL Science (SLBT), CAMP4 (CAMP), and Beyond Air (XAI

Goodman Robert Scott (Chief Executive Officer) purchased 34,722 shares of Beyond Air, Inc. (XAIR) at $5.76 ($0.20M total) on 2026-07-29.

MOORHEAD DANIEL J (Chief Financial Officer) purchased 4,340 shares of Beyond Air, Inc. (XAIR) at $5.76 on 2026-07-29.

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 5 ex10-1.htm EX-10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “ Agreement ”) is dated as of July 29, 2026, by and among Beyond Air, Inc., a Delaware corporation (the “ Company ”), and each of the entities listed on Exhibit A atta

Beyond Air (XAIR) reported fiscal 2026 revenue of $7.7 million (+107%) and Q4 revenue of $1.9 million (+66%). Management cited ~90% customer renewal and expects CY 2026 revenue guidance of $8 million and CY 2027 of $16–$18 million. Gross profit was $0.3 million vs a prior-year loss; net loss was $33.2 million. The company also approved a 1-for-20 reverse stock split and guided on Gen 2 regulatory approval as a key catalyst.

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update Revenue increased by 107% year-over-year to $7.7 million in the full fiscal year 2026; increased revenue by 66% YoY in the fiscal fourth

Beyond Air, Inc. (XAIR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001641631 0001641631 2026-06-18 2026-06-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of repor

Beyond Air, Inc. (Nasdaq: XAIR) urged stockholders to vote “FOR” all proposals at a special meeting on June 18, 2026. The company said Nasdaq notified it on April 7, 2026 that it failed the $1.00 minimum bid price for 30 straight days, risking delisting. Proposal 1 would allow a 1-for-2 to 1-for-20 reverse split to restore compliance.

Beyond Air (NASDAQ:XAIR) announced the resignation of CEO Steve Lisi and the appointment of Robert Goodman as his successor, effective March 27, 2026. The leadership change comes as the company's stock trades near its 52-week low, and BTIG has reiterated a Neutral rating, awaiting sustained commercial execution and improved cost control. Beyond Air also reported a revenue increase and reduced operating expenses in Q3 FY2026 while continuing various strategic initiatives and research.

With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Chagee Holdings Ltd. ( NASDAQ:CHA ) to report quarterly earnings of 40 cents per share on revenue of $458.31 million before the opening bell, ...